The 300 or so employees of BVA in France are in expectation.
Placed in recovery in June to face cash flow problems, the research company is in an uncomfortable situation.
Last Tuesday, the Toulouse commercial court decided to attribute the takeover of its four French companies to the British fund Alcentra, its first creditor.
But Thursday, to everyone's surprise, the prosecution appealed against this decision.
The consular justice is therefore called upon to re-examine the four takeover offers already submitted to its assessment.
In this battle, two camps clash: Alcentra, a debt fund held by Bank of New York Mellon, and the current management of BVA, mainly its president, Gérard Lopez, its managing director, Pascal Gaudin, and three other executives. .
The reasons why the prosecution opposed the choice of court are not known.
But BVA managers point to several elements.
They notably support
This article is for subscribers only.
You have 71% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
Enter your email
Already subscribed?
Log in